<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Med</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1076-1551</issn>
<issn pub-type="epub">1528-3658</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30813884</article-id>
<article-id pub-id-type="pmc">6391808</article-id>
<article-id pub-id-type="publisher-id">73</article-id>
<article-id pub-id-type="doi">10.1186/s10020-019-0073-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Further corroboration of distinct functional features in <italic>SCN2A</italic> variants causing intellectual disability or epileptic phenotypes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Begemann</surname>
<given-names>Anaïs</given-names>
</name>
<address>
<email>begemann@medgen.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Acuña</surname>
<given-names>Mario A.</given-names>
</name>
<address>
<email>acuna@pyl.unibe.ch</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zweier</surname>
<given-names>Markus</given-names>
</name>
<address>
<email>zweier@medgen.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vincent</surname>
<given-names>Marie</given-names>
</name>
<address>
<email>Marie.VINCENT@chu-nantes.fr</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steindl</surname>
<given-names>Katharina</given-names>
</name>
<address>
<email>steindl@medgen.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bachmann-Gagescu</surname>
<given-names>Ruxandra</given-names>
</name>
<address>
<email>ruxandra.bachmann@imls.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hackenberg</surname>
<given-names>Annette</given-names>
</name>
<address>
<email>Annette.Hackenberg@kispi.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abela</surname>
<given-names>Lucia</given-names>
</name>
<address>
<email>abela.lucia@bluewin.ch</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Plecko</surname>
<given-names>Barbara</given-names>
</name>
<address>
<email>barbara.plecko@medunigraz.at</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kroell-Seger</surname>
<given-names>Judith</given-names>
</name>
<address>
<email>Judith.Kroell@kliniklengg.ch</email>
</address>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baumer</surname>
<given-names>Alessandra</given-names>
</name>
<address>
<email>baumer@medgen.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamakawa</surname>
<given-names>Kazuhiro</given-names>
</name>
<address>
<email>yamakawa@brain.riken.jp</email>
</address>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inoue</surname>
<given-names>Yushi</given-names>
</name>
<address>
<email>yinoue-jes@umin.net</email>
</address>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Asadollahi</surname>
<given-names>Reza</given-names>
</name>
<address>
<email>asadollahi@medgen.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sticht</surname>
<given-names>Heinrich</given-names>
</name>
<address>
<email>heinrich.sticht@fau.de</email>
</address>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zeilhofer</surname>
<given-names>Hanns Ulrich</given-names>
</name>
<address>
<email>zeilhofer@pharma.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff11">11</xref>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Rauch</surname>
<given-names>Anita</given-names>
</name>
<address>
<phone>+41 44 556 3300</phone>
<email>anita.rauch@medgen.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff12">12</xref>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Institute of Medical Genetics, </institution><institution>University of Zurich, </institution></institution-wrap>8952 Schlieren, Zurich Switzerland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>radiz—Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases, </institution><institution>University of Zurich, </institution></institution-wrap>8006 Zurich, Switzerland </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Institute of Pharmacology and Toxicology, </institution><institution>University of Zurich, </institution></institution-wrap>8057 Zurich, Switzerland </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0472 0371</institution-id><institution-id institution-id-type="GRID">grid.277151.7</institution-id><institution>Service de génétique médicale, CHU Nantes, </institution></institution-wrap>44093 Nantes, France </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0726 4330</institution-id><institution-id institution-id-type="GRID">grid.412341.1</institution-id><institution>Division of Child Neurology, </institution><institution>University Children’s Hospital Zurich, </institution></institution-wrap>8032 Zurich, Switzerland </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8988 2476</institution-id><institution-id institution-id-type="GRID">grid.11598.34</institution-id><institution>Division of General Pediatrics, Department of Pediatrics and Adolescent Medicine, </institution><institution>Medical University of Graz, </institution></institution-wrap>8036 Graz, Austria </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2235 3868</institution-id><institution-id institution-id-type="GRID">grid.419749.6</institution-id><institution>Children’s department, Swiss Epilepsy Centre, Clinic Lengg, </institution></institution-wrap>8008 Zurich, Switzerland </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.474690.8</institution-id><institution>Laboratory for Neurogenetics, RIKEN Center for Brain Science, </institution></institution-wrap>Wako-shi, Saitama, 351-0198 Japan </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0618 9684</institution-id><institution-id institution-id-type="GRID">grid.419174.e</institution-id><institution>National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, </institution></institution-wrap>Shizuoka, 420-8688 Japan </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), </institution></institution-wrap>91054 Erlangen, Germany </aff>
<aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 2780</institution-id><institution-id institution-id-type="GRID">grid.5801.c</institution-id><institution>Institute of Pharmaceutical Sciences, ETH Zurich, </institution></institution-wrap>8093 Zürich, Switzerland </aff>
<aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Neuroscience Center Zurich, </institution><institution>University of Zurich and ETH Zurich, </institution></institution-wrap>8057 Zurich, Switzerland </aff>
<aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Zurich Center for Integrative Human Physiology, </institution><institution>University of Zurich, </institution></institution-wrap>8057 Zurich, Switzerland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>27</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>25</volume>
<elocation-id>6</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Deleterious variants in the voltage-gated sodium channel type 2 (Na<sub>v</sub>1.2) lead to a broad spectrum of phenotypes ranging from benign familial neonatal-infantile epilepsy (BFNIE), severe developmental and epileptic encephalopathy (DEE) and intellectual disability (ID) to autism spectrum disorders (ASD). Yet, the underlying mechanisms are still incompletely understood.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">To further elucidate the genotype-phenotype correlation of <italic>SCN2A</italic> variants we investigated the functional effects of six variants representing the phenotypic spectrum by whole-cell patch-clamp studies in transfected HEK293T cells and in-silico structural modeling.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">The two variants p.L1342P and p.E1803G detected in patients with early onset epileptic encephalopathy (EE) showed profound and complex changes in channel gating, whereas the BFNIE variant p.L1563V exhibited only a small gain of channel function. The three variants identified in ID patients without seizures, p.R937C, p.L611Vfs*35 and p.W1716*, did not produce measurable currents. Homology modeling of the missense variants predicted structural impairments consistent with the electrophysiological findings.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">Our findings support the hypothesis that complete loss-of-function variants lead to ID without seizures, small gain-of-function variants cause BFNIE and EE variants exhibit variable but profound Na<sub>v</sub>1.2 gating changes. Moreover, structural modeling was able to predict the severity of the variant impact, supporting a potential role of structural modeling as a prognostic tool. Our study on the functional consequences of <italic>SCN2A</italic> variants causing the distinct phenotypes of EE, BFNIE and ID contributes to the elucidation of mechanisms underlying the broad phenotypic variability reported for <italic>SCN2A</italic> variants.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s10020-019-0073-6) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>
<italic>SCN2A</italic>
</kwd>
<kwd>Nav1.2</kwd>
<kwd>Channelopathy</kwd>
<kwd>Patch-clamp</kwd>
<kwd>Epilepsy</kwd>
<kwd>Epileptic encephalopathy</kwd>
<kwd>Intellectual disability</kwd>
<kwd>Structural modelling</kwd>
<kwd>Electrophysiology</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>radiz—Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases of the University of Zurich</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id>
<institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution>
</institution-wrap>
</funding-source>
<award-id>320030_179547</award-id>
<principal-award-recipient>
<name>
<surname>Rauch</surname>
<given-names>Anita</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Forschungskredit UZH</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Josef Huwyler Ruth Bernet-Engeli Stiftung</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par17"><italic>SCN2A</italic> (OMIM 182390) encodes the pore-forming α-subunit of the voltage gated sodium channel type 2 (Na<sub>v</sub>1.2). It is predominantly expressed at the axon initial segment and nodes of Ranvier of excitatory neurons of the central nervous system and plays a crucial role for axon potential initiation and propagation in early development (Kaplan et al. <xref ref-type="bibr" rid="CR17">2001</xref>, Kole and Stuart <xref ref-type="bibr" rid="CR20">2012</xref>). At age 1–2 years, it is partially replaced by Na<sub>v</sub>1.6 (encoded by <italic>SCN8A</italic>) and its main function is then thought to be related to the support of backpropagating action potentials (Hu et al. <xref ref-type="bibr" rid="CR14">2009</xref>, Sanders et al. <xref ref-type="bibr" rid="CR42">2018</xref>). Variants in <italic>SCN2A</italic> were initially identified as disease cause in patients with generalized epilepsy with febrile seizures plus (GEFS+) (Sugawara et al. <xref ref-type="bibr" rid="CR47">2001</xref>) and benign familial neonatal-infantile epilepsy (BFNIE) (Heron et al. <xref ref-type="bibr" rid="CR12">2002</xref>). In recent years, <italic>SCN2A</italic> has been recognized as one of the most frequently mutated genes in neurodevelopmental disorders including autism spectrum disorders (ASD), intellectual disability (ID), developmental and epileptic encephalopathy (DEE) and schizophrenia (Li et al. <xref ref-type="bibr" rid="CR23">2016</xref>).</p>
<p id="Par18">Given the broad clinical spectrum associated with pathogenic variants in this gene, understanding the genotype-phenotype correlation is a prerequisite for proper treatment and genetic counselling. To date, categorization of <italic>SCN2A</italic> variants by variant type and location allows limited prediction of the associated phenotype. Causative variants observed in BFNIE and DEE are usually missense variants clustering in the transmembrane segments and short connecting loops (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>), while more than half of the ASD-associated <italic>SCN2A</italic> variants are predicted to introduce a premature stop codon (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). However, there are also reports of patients with nonsense, frameshift and splice site variants showing a variety of seizure types (Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>). Electrophysiological analyses of about 20 pathogenic variants mostly in HEK cells and computational modeling of neuronal excitability suggest a gain of channel function and modest neuronal hyperexcitability in BFNIE, while DEE pathogenic variants show more marked and variable gating changes with pronounced hyper- or hypoexcitability predicted by in-silico modeling of six variants (Sugawara et al. <xref ref-type="bibr" rid="CR47">2001</xref>, Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>, Scalmani et al. <xref ref-type="bibr" rid="CR44">2006</xref>, Xu et al. <xref ref-type="bibr" rid="CR53">2007</xref>, Misra et al. <xref ref-type="bibr" rid="CR31">2008</xref>, Ogiwara et al. <xref ref-type="bibr" rid="CR34">2009</xref>, Liao, Anttonen, et al. <xref ref-type="bibr" rid="CR24">2010a</xref>, Liao, Deprez, et al. <xref ref-type="bibr" rid="CR25">2010b</xref>, Lossin et al. <xref ref-type="bibr" rid="CR26">2012</xref>, Lauxmann et al. <xref ref-type="bibr" rid="CR21">2013</xref>, Schwarz et al. <xref ref-type="bibr" rid="CR45">2016</xref>, Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>, Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>, Lauxmann et al. <xref ref-type="bibr" rid="CR22">2018</xref>). Gain of function variants were significantly associated with seizure onset before 3 months of age and a better response to sodium channel blockers, while loss of function variants were more often observed with later onset epilepsy and no or even adverse responses to sodium channel blockers (Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>). One study investigating <italic>SCN2A</italic> variants associated with ASD (with or without seizures) in HEK cells showed partial or complete loss of channel function in all variants (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). A recently proposed bidirectional hypothesis suggesting that gain of channel function leads to epileptic phenotypes whereas loss of channel function results in ID/ASD phenotypes (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>, Sanders et al. <xref ref-type="bibr" rid="CR42">2018</xref>) has been challenged by conflicting findings indicating hypoexcitability in infantile epileptic encephalopathy (EE) (Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>). Therefore, characterization of additional <italic>SCN2A</italic> variants should help to improve genotype-phenotype correlation eventually enabling mechanism-based therapy (Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>, Sanders et al. <xref ref-type="bibr" rid="CR42">2018</xref>, Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>, Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>).</p>
<p id="Par19">Here, we investigated the functional consequences of six <italic>SCN2A</italic> variants identified in patients with ID without seizures, early-onset EE or BFNIE using whole-cell patch-clamp experiments in HEK293T cells transiently expressing wild-type or mutant Na<sub>v</sub>1.2. Furthermore, the description of homologous structures in 2017 (Yan et al. <xref ref-type="bibr" rid="CR54">2017</xref>, Shen et al. <xref ref-type="bibr" rid="CR46">2017</xref>) allowed us to generate a 3D-model for SCN2A and assess the impact of the different variants on protein structure. We further re-evaluated the first family reported with a pathogenic <italic>SCN2A</italic> variant causing DEE (p.R102*) (Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>) which stands out as the only functionally studied truncating variant leading to DEE.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Patients and variants</title>
<p id="Par20">Five previously reported patients carrying a pathogenic <italic>SCN2A</italic> variant (Hackenberg et al. <xref ref-type="bibr" rid="CR11">2014</xref>, Rauch et al. <xref ref-type="bibr" rid="CR40">2012</xref>, Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>, Papuc et al. <xref ref-type="bibr" rid="CR37">2018</xref>) with a phenotype of either early-onset EE (<italic>n</italic> = 2) or ID without seizures (<italic>n</italic> = 3) were included in this study for functional and clinical evaluation. One BFNIE variant previously studied extensively by others was also investigated as a reference.</p>
</sec>
<sec id="Sec4">
<title>Whole exome sequencing</title>
<p id="Par21">To re-evaluate the DEE case published by Kamiya et al. in <xref ref-type="bibr" rid="CR16">2004</xref> carrying the p.R102* variant detected by targeted sequencing of <italic>SCN2A</italic>, we now performed trio whole exome sequencing (WES) of this family (see Additional file <xref ref-type="media" rid="MOESM1">1</xref>).</p>
</sec>
<sec id="Sec5">
<title>Mutagenesis and cell culture</title>
<p id="Par22">Human <italic>SCN2A</italic> (‘adult’ isoform (Kasai et al. <xref ref-type="bibr" rid="CR18">2001</xref>), RefSeq NM_021007 (O’Leary et al. <xref ref-type="bibr" rid="CR36">2016</xref>)), <italic>SCN1B</italic> (NM_001037) and <italic>SCN2B</italic> (NM_004588) cDNA in pCMV6-XL4/5 expression vectors were purchased from OriGene (Rockville, MD, USA). Mutagenesis was performed by Creative Biolabs (Shirley, NY, USA) and verified by sequencing. HEK293T cells (ATCC-LGC Standards, Manassas, VA, USA) were grown in DMEM supplemented with 9% fetal bovine serum and 1% Pen Strep (all Gibco, Carlsbad, CA, USA). Cells were transiently transfected using Lipofectamine LTX with PLUS Reagent (Invitrogen, Carlsbad, CA, USA). Wild-type or mutated Na<sub>v</sub>1.2 α-subunit (1 μg) was co-expressed with β1- and β2-subunits and EGFP (in a ratio of 1:1:1:0.5, respectively). Recordings were made exclusively from EGFP-positive cells.</p>
</sec>
<sec id="Sec6">
<title>Electrophysiology</title>
<p id="Par23">Whole-cell voltage-clamp recordings were performed at room temperature 18–30 h after transfection using 2–4 MΩ borosilicate glass pipettes, an EPC7 amplifier and Patchmaster v2.11 software (HEKA Elektronik Dr. Schulze GmbH, Lambrecht, Germany). The pipette solution contained (in mM) 110 CsF, 10 NaF, 20 CsCl, 2 EGTA and 10 HEPES ~ 310 mOsm (pH 7.35 with CsOH). Bath solution consisted of (in mM) 145 NaCl, 4 KCl, 1.8 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub> and 10 HEPES ~ 310 mOsm (pH 7.35 with NaOH). Cells with peak current amplitudes &lt; 0.6 nA were not used for analysis of biophysical parameters due to possible contamination with endogenous currents of HEK cells. Whole-cell capacitance was determined by integrating the area under the capacitive currents in response to a hyperpolarizing voltage step<italic>.</italic> Capacitive transients were compensated electronically. Leak currents were subtracted by use of a P/N procedure. Sodium currents were evoked by 10 ms voltage steps from − 100 mV to + 50 mV from a holding potential of − 120 mV. Current densities were obtained by dividing the peak currents by the capacitance. Charge transfer was calculated as the area under the current trace and normalized to the capacitance. Sodium conductance (G<sub>Na</sub>) was calculated as G<sub>Na</sub> = I<sub>Na</sub> / (V<sub>m</sub> − V<sub>rev</sub>), where I<sub>Na</sub> is the measured peak current at the test potential V<sub>m</sub>, and V<sub>rev</sub> is the calculated sodium reversal potential. To obtain activation curves (conductance-voltage relationship), the normalized conductance was plotted against the test potentials and fitted with a Boltzmann sigmoidal function for quantitative analysis. The 10–90% rise time was obtained from the I-V current traces. Fast and slow inactivation time constants were obtained by fitting a second order exponential function to the current decay of the I-V current traces. Steady-state inactivation was determined using 500 ms conditioning prepulses to potentials varying from − 130 to + 10 mV followed by a depolarizing test pulse to + 5 mV. For quantitative analysis, normalized peak currents were plotted against prepulse potential and fitted with a Boltzmann sigmoidal function. Recovery from fast inactivation was recorded by a two-pulse protocol from a holding potential of − 90 mV to + 5 mV with increasing interpulse intervals. For quantitative analyses, the curves were fitted with a first order exponential function where the tau represents the recovery time constant. To analyze use-dependent inactivation, depolarizing pulse trains from − 90 mV to + 10 mV at different frequencies were applied and the residual peak current of the last pulse was normalized to the peak current of the first pulse.</p>
<p id="Par24">Results are presented as mean ± SEM. Statistical significance of differences in reference to wild-type was calculated by using the unpaired Student’s t test and a significance level of <italic>p</italic> &lt; 0.05. Data were analyzed using NeuroMatic v2.00 (Rothman and Silver <xref ref-type="bibr" rid="CR41">2018</xref>) within Igor Pro 6.3 software (WaveMetrics, Portland, OR, USA) and GraphPad Prism 7.0 software (GraphPad Software, La Jolla, CA, USA).</p>
</sec>
<sec id="Sec7">
<title>Protein modeling</title>
<p id="Par25">The structure of SCN2A was modeled with Modeller 9.16 (Webb and Sali <xref ref-type="bibr" rid="CR50">2017</xref>) using the recently published structure of a homologous voltage-gated sodium channel (PDB: 5X0M (Shen et al. <xref ref-type="bibr" rid="CR46">2017</xref>)) as template. Residues 440–741 and 990–1184 were excluded from the modeling procedure because they were either absent in the template or they did not exhibit a sufficient sequence similarity between template and target sequence. RasMol (Sayle and Milner-White <xref ref-type="bibr" rid="CR43">1995</xref>) was used for structure analysis and visualization.</p>
</sec>
</sec>
<sec id="Sec8">
<title>Results</title>
<sec id="Sec9">
<title>Patient phenotypes and variants</title>
<p id="Par26">Comprehensive phenotypes of our patients and bioinformatic annotations of their respective variants are presented in Table <xref ref-type="table" rid="Tab1">1</xref> and their location in the 2D-scheme of the Na<sub>v</sub>1.2 channel is depicted in Fig. <xref ref-type="fig" rid="Fig1">1</xref>. All missense variants affect a highly conserved amino acid and have damaging in-silico predictions.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Molecular data and patient phenotypes</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Patient 1 / ID</th><th>Patient 2 / ID</th><th>Patient 3 / EE</th><th>Patient 4 / ID</th><th>Patient 5 / EE</th><th>Published BFNIE family</th></tr></thead><tbody><tr><td>Previous publication</td><td>Rauch et al. <xref ref-type="bibr" rid="CR40">2012</xref><break></break>ER8490</td><td>Rauch et al. <xref ref-type="bibr" rid="CR40">2012</xref><break></break>ZH60991</td><td>Hackenberg et al. <xref ref-type="bibr" rid="CR11">2014</xref><break></break>ZH62611</td><td>Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref><break></break>Patient 63</td><td>Papuc et al. <xref ref-type="bibr" rid="CR37">2018</xref><break></break>ID42680</td><td rowspan="2">Heron et al. <xref ref-type="bibr" rid="CR12">2002</xref>;<break></break>Functional characterization by Scalmani et al. <xref ref-type="bibr" rid="CR44">2006</xref>,<break></break>Xu et al. <xref ref-type="bibr" rid="CR53">2007</xref>,<break></break>Misra et al. <xref ref-type="bibr" rid="CR31">2008</xref>,<break></break>Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref></td></tr><tr><td>Additional reports on the same variant</td><td>Li et al. <xref ref-type="bibr" rid="CR23">2016</xref> (due to a repeat shift described as p.D609fs), ID</td><td>Functional studies by Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref></td><td>Dimassi et al. <xref ref-type="bibr" rid="CR8">2016</xref><break></break>Matalon et al. <xref ref-type="bibr" rid="CR28">2014</xref><break></break>Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref><break></break>All EE</td><td>–</td><td>–</td></tr><tr><td>Type of variant</td><td>het. frameshift</td><td>het. missense</td><td>het. missense</td><td>het. stop</td><td>het. missense</td><td>het. missense</td></tr><tr><td>Inheritance</td><td>de novo</td><td>de novo</td><td>de novo</td><td>de novo</td><td>de novo</td><td>Inherited from a parent</td></tr><tr><td>cDNA level<sup>a</sup></td><td>c.1831_1832delCT</td><td>c.2809C&gt;T</td><td>c.4025T&gt;C</td><td>c.5147G&gt;A</td><td>c.5408A&gt;G</td><td>c.4687C&gt;G</td></tr><tr><td>Protein level</td><td>p.(L611Vfs*35)</td><td>p.(R937C)</td><td>p.(L1342P)</td><td>p.(W1716*)</td><td>p.(E1803G)</td><td>p.(L1563V)</td></tr><tr><td>rs number (dbSNP<sup>b</sup>)</td><td>unreported</td><td>rs796053197</td><td>rs796053134</td><td>unreported</td><td>unreported</td><td>rs121917750</td></tr><tr><td>Chromosomal position (hg19)</td><td>chr2:166179821–166179822</td><td>chr2:166201311</td><td>chr2:166231247</td><td>chr2:166245463</td><td>chr2:166245724</td><td>chr2:166243391</td></tr><tr><td>Allele Frequency (GnomAD<sup>c</sup>)</td><td>unreported</td><td>unreported</td><td>unreported</td><td>unreported</td><td>unreported</td><td>unreported</td></tr><tr><td>Conservation<sup>d</sup>,<break></break>location in protein</td><td>/</td><td>high,<break></break>DII S5–6</td><td>high,<break></break>DIII S5</td><td>/</td><td>high,<break></break>C-terminus</td><td>high,<break></break>DIV S2</td></tr><tr><td>Established Prediction tools<sup>e</sup></td><td>/</td><td>probably damaging</td><td>probably damaging</td><td>/</td><td>probably damaging</td><td>probably damaging</td></tr><tr><td>Age at last investigation</td><td>18y 1m</td><td>22y 9m</td><td>6y 8m</td><td>24y 4m</td><td>16y 4m</td><td></td></tr><tr><td>Gender</td><td>male</td><td>female</td><td>female</td><td>female</td><td>male</td><td></td></tr><tr><td>Consanguinity, ethnicity</td><td>no, German</td><td>no, Swiss</td><td>no, Japanese/Swiss</td><td>no, Swiss</td><td>no, Swiss</td><td></td></tr><tr><td>Pre- or perinatal anomalies</td><td>none</td><td>none</td><td>none</td><td>none</td><td>none</td><td></td></tr><tr><td>Gestational age (weeks)</td><td>41</td><td>40 3/7</td><td>38 5/7</td><td>term</td><td>41 1/7</td><td></td></tr><tr><td>Birth weight / length / HC</td><td>3600 g / 52 cm / 35 cm</td><td>3800 g / 51 cm / NA</td><td>2970 g / 48 cm / 36 cm</td><td>3150 g / NA / NA</td><td>4120 g / 51 cm / NA</td><td></td></tr><tr><td>Intellectual disability</td><td>yes (IQ 58)</td><td>yes (IQ &lt; 50)</td><td>yes, severe</td><td>yes, mild<break></break>reading capital letters, calculating with numbers up to 10</td><td>yes, severe</td><td></td></tr><tr><td>Autistic features</td><td>yes</td><td>yes</td><td>NA</td><td>yes</td><td>NA</td><td></td></tr><tr><td>Other abnormal behavior</td><td>compulsive stereotypies,<break></break>autoaggressive behavior</td><td>compulsive stereotypies,<break></break>autoaggressive behavior</td><td>none</td><td>recurrent episodes of mutism and psychotic episodes</td><td>none</td><td></td></tr><tr><td>Developmental delay<break></break>Age of indep. walking<break></break>Age of first words<break></break>Speech development</td><td>yes<break></break>13 m<break></break>12 m<break></break>Speaks sentences</td><td>yes<break></break>24 m<break></break>24 m<break></break>Simple sentences</td><td>yes<break></break>no indep. sitting or walking<break></break>-<break></break>no speech</td><td>yes<break></break>24 m<break></break>delayed</td><td>yes<break></break>no indep. sitting or walking<break></break>-<break></break>no speech</td><td></td></tr><tr><td>Seizures (onset)</td><td>none</td><td>none</td><td>yes (diagnosis at 5 m)</td><td>none</td><td>yes (day 3)</td><td></td></tr><tr><td>Seizure type</td><td>/</td><td>/</td><td>myoclonic / tonic</td><td>/</td><td>myoclonic / tonic</td><td></td></tr><tr><td>Course of epilepsy</td><td>/</td><td>/</td><td>at least 3 seizures per day, pharmacoresistant</td><td>/</td><td>1–7 seizures per day, pharmacoresistant</td><td></td></tr><tr><td>Acquired microcephaly</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>no</td><td></td></tr><tr><td>Muscle tone abnormalities, movement disorders</td><td>none</td><td>hypotonia</td><td>severe hypotonia, choreoathetotic<break></break>movements</td><td>none</td><td>spasticity, bilateral contractures of knees</td><td></td></tr><tr><td>Dysmorphisms</td><td>long face, narrow palpebral fissures, and relatively thick eyebrows, narrow palate, inverted nipples, tapering fingers</td><td>long face, narrow palpebral fissures, mild brachymetacarpalia Dig. IV-V, tapering fingers</td><td>none</td><td>NA</td><td>high, narrow palate</td><td></td></tr><tr><td>Other health problems</td><td>hyperopia</td><td>myopia</td><td>OSAS, scoliosis, hip dysplasia left, hip subluxation right, recurring respiratory infections</td><td>none reported</td><td>cortical visual impairment, gastro-jejunal tube</td><td></td></tr><tr><td>EEG</td><td>normal</td><td>NA</td><td>multifocal sharp wave activity, hypsarrhythmia</td><td>normal</td><td>frontocentral spike-wave activity on both sides, burst suppression</td><td></td></tr><tr><td>MRI</td><td>pinealis cyst</td><td>NA</td><td>progressive brain atrophy</td><td>normal</td><td>normal at age 4d, generalized supra- and infratentorial atrophy, bilateral hippocampal atrophy, left-sided hippocampal sclerosis and atrophy of corpus callosum at age 14y</td><td></td></tr></tbody></table><table-wrap-foot><p>Abb: / not relevant for this case; <italic>D</italic> domain, <italic>het</italic> heterozygous, <italic>EEG</italic> electroencephalogram, <italic>HC</italic> head circumference, <italic>m</italic> months, <italic>MRI</italic> magnetic resonance imaging, <italic>NA</italic> not available, <italic>S</italic> segment; <italic>y</italic> years</p><p><sup>a</sup>according to reference sequence NM_021007</p><p>
<sup>b</sup>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/SNP">https://www.ncbi.nlm.nih.gov/SNP</ext-link>
</p><p>
<sup>c</sup>
<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org">http://gnomad.broadinstitute.org</ext-link>
</p><p><sup>d</sup>according to Alamut Visual v.2.8.1</p><p><sup>e</sup>Polyphen2, MutationTaster, SIFT assessed by Alamut Visual v.2.8.1</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic drawing of SCN2A indicating the location of studied pathogenic variants. The three patients with ID without seizures carried de novo heterozygous variants in <italic>SCN2A</italic> (shown in blue), two of which are nonsense variants (p.L611Vfs*35 and p.W1716*) and one is a missense variant in the pore-forming loop of domain 2 of the channel (p.R937C). The two patients with early onset EE harbored de novo heterozygous missense variants (shown in red) in the fifth transmembrane segment of the third channel domain (p.L1342P) or the C-terminal domain (p.E1803G), respectively. The heterozygous inherited missense variant previously reported by others in a family with BFNIE (Heron et al. <xref ref-type="bibr" rid="CR12">2002</xref>) (shown in green) is located in the second transmembrane segment of domain 4 (p.L1563V). Adapted from Meisler and Kearney (<xref ref-type="bibr" rid="CR29">2005</xref>)</p></caption><graphic id="MO1" xlink:href="10020_2019_73_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec10">
<title>ID mutants are non-conducting</title>
<p id="Par27">Representative families of whole-cell current traces of wild-type and conducting mutant channels are shown in Fig. <xref ref-type="fig" rid="Fig2">2</xref>a, while Fig. <xref ref-type="fig" rid="Fig2">2</xref>b depicts the peak current amplitude normalized by cell capacitance for wild-type and mutant Na<sub>v</sub>1.2. Recombinant Na<sub>v</sub>1.2 channels carrying variants from ID patients showed no or only small residual currents indistinguishable from endogenous HEK293T cell currents (Zhu et al. <xref ref-type="bibr" rid="CR55">1998</xref>, Cummins et al. <xref ref-type="bibr" rid="CR7">1993</xref>) (mean peak current wild-type = − 1131 ± 190 pA, <italic>n</italic> = 8; R937C = − 271 ± 46 pA, <italic>n</italic> = 9; L611Vfs*35 = − 258 ± 52 pA, <italic>n</italic> = 10; W1716* = − 253 ± 45 pA, <italic>n</italic> = 8). Thus, ID variants resulted in a complete loss of Na<sub>v</sub>1.2-mediated current. The mean peak current density of the EE and BFNIE Na<sub>v</sub>1.2 mutants did not differ significantly from the wild-type (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b, Table <xref ref-type="table" rid="Tab2">2</xref>). Striking alterations were observed in other functional characteristics as described below.<fig id="Fig2"><label>Fig. 2</label><caption><p>Patch-clamp recordings in HEK293T cells expressing recombinant Na<sub>v</sub>1.2 wild-type or mutant channels. Variants E1803G (blue) and L1342P (green) have been detected in patients with EE, L1563V (red) in a family with BFNIE, and R937C (purple), L611Vfs*35 (orange) and W1716* (light blue) cause ID. <bold>a</bold> Family of whole-cell sodium currents of wild-type and conducting mutant Na<sub>v</sub>1.2. <bold>b</bold> Peak current amplitudes normalized to cell capacitance (bars are mean ± SEM) were not significantly different. <bold>c</bold> Voltage dependence of activation obtained by plotting the normalized conductance against test potentials and fitted with a Boltzmann function. L1342P showed a significant negative shift (<italic>p</italic> &lt; 0.001). <bold>d</bold> Voltage dependence of steady-state inactivation obtained by displaying the normalized current amplitude against the prepulse potential fitted with a Boltzmann function. A negative shift was observed for both L1342P (<italic>p</italic> &lt; 0.001) and L1563 V (<italic>p</italic> = 0.017), while E1803G had a shallower slope (<italic>p</italic> &lt; 0.001). <bold>e</bold> Activation and inactivation curves of L1342P in comparison to wild-type demonstrating a hyperpolarized shift with unchanged activation-inactivation coupling. <bold>f</bold> Activation and inactivation curves of E1803G in comparison to wild-type illustrating the increase of the window current. <bold>g</bold> Time-dependent recovery from inactivation fitted with a single exponential function and plotted against a logarithmic time scale. A significantly slower recovery rate was observed in L1342P (<italic>p</italic> = 0.002). <bold>h</bold> Use-dependent inactivation. The frequencies of depolarizing pulse trains are plotted against the residual peak current amplitude of the last pulse normalized to the peak current amplitude of the first pulse. <bold>i</bold> 10–90% rise time depicted against test potentials. L1342P exhibited a significantly faster rise time at the voltage step to − 30 mV (<italic>p</italic> = 0.02). <bold>k</bold> Fast inactivation time constants plotted against test potentials</p></caption><graphic id="MO2" xlink:href="10020_2019_73_Fig2_HTML"></graphic></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Biophysical parameters of Na<sub>v</sub>1.2 wild-type and mutants</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"></th><th colspan="2">Peak current density</th><th colspan="3">Voltage dep. of steady-state inactivation</th><th colspan="3">Voltage dep. of steady-state activation</th><th colspan="2">Recovery from inactivation</th><th colspan="2">10–90% rise time</th><th colspan="2">Fast decay time constant</th></tr><tr><th>Mean peak amplitude (pA/pF)</th><th>n</th><th>V<sub>1/2</sub> (mV)</th><th>
<italic>k</italic>
</th><th>n</th><th>V<sub>1/2</sub> (mV)</th><th>
<italic>k</italic>
</th><th>n</th><th>τ<sub>rec</sub> (ms)</th><th>n</th><th>t at 0 mV (ms)</th><th>n</th><th>τ<sub>fast</sub> at 0 mV (ms)</th><th>n</th></tr></thead><tbody><tr><td>wild-type</td><td>−54.24 ± 12.60</td><td>8</td><td>−63.53 ± 0.79</td><td>−6.91 ± 0.69</td><td>9</td><td>−23.87 ± 0.64</td><td>6.46 ± 0.57</td><td>9</td><td>7.02 ± 0.86</td><td>9</td><td>0.38 ± 0.05</td><td>9</td><td>0.58 ± 0.07</td><td>9</td></tr><tr><td>L1342P</td><td>− 108.80 ± 23.20</td><td>9</td><td>−79.71 ± 1.18**</td><td>− 8.30 ± 1.02</td><td>9</td><td>−39.07 ± 0.82**</td><td>7.25 ± 0.73</td><td>9</td><td>15.03 ± 2.18*</td><td>6</td><td>0.26 ± 0.03</td><td>9</td><td>0.51 ± 0.06</td><td>9</td></tr><tr><td>E1803G</td><td>−53.48 ± 12.28</td><td>8</td><td>−60.90 ± 1.87</td><td>−12.35 ± 1.00**</td><td>8</td><td>−23.61 ± 0.88</td><td>7.38 ± 0.78</td><td>8</td><td>10.04 ± 1.91</td><td>7</td><td>0.48 ± 0.08</td><td>7</td><td>0.90 ± 0.11</td><td>7</td></tr><tr><td>L1563V</td><td>−90.55 ± 20.97</td><td>6</td><td>−59.77 ± 1.21*</td><td>−8.75 ± 1.07</td><td>6</td><td>−25.17 ± 0.61</td><td>5.37 ± 0.53</td><td>6</td><td>6.05 ± 1.27</td><td>6</td><td>0.40 ± 0.06</td><td>6</td><td>0.66 ± 0.08</td><td>6</td></tr></tbody></table><table-wrap-foot><p>Values significantly different from wild-type are indicated as follows ∗<italic>p</italic> &lt; 0.05, ∗∗<italic>p</italic> &lt; 0.001</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec11">
<title>The EE mutant L1342P shows a hyperpolarizing shift of activation and inactivation curves</title>
<p id="Par28">Voltage-dependent activation and inactivation curves of L1342P exhibited a hyperpolarizing shift of about 15 mV relative to wild-type (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c-e, Table <xref ref-type="table" rid="Tab2">2</xref>). Furthermore, this mutant showed a slower recovery time constant from inactivation (Fig. <xref ref-type="fig" rid="Fig2">2</xref>g, Table <xref ref-type="table" rid="Tab2">2</xref>) and a trend towards faster rise time kinetics, although reaching significance only at − 30 mV (Fig. <xref ref-type="fig" rid="Fig2">2</xref>i, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). Differences in the current density, decay kinetics and use-dependent inactivation were not statistically significant (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b, h and k, Table <xref ref-type="table" rid="Tab2">2</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2). Therefore, this mutant showed mixed gain and loss of function effects.</p>
</sec>
<sec id="Sec12">
<title>The EE mutant E1803G exhibits a shallower slope of the inactivation curve that leads to an increased window current</title>
<p id="Par29">While no changes in voltage dependence of activation were observed for the mutant E1803G compared to wild-type, the slope of the voltage dependence of inactivation was significantly less steep (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c-d, Table <xref ref-type="table" rid="Tab2">2</xref>), leading to a larger overlap of activation and inactivation curves. This increased window current suggests the presence of a persistent current at membrane voltages between − 45 to − 25 mV (Fig. <xref ref-type="fig" rid="Fig2">2</xref>f). Additionally, the E1803G mutant tended to have slower activation and inactivation kinetics (Fig. <xref ref-type="fig" rid="Fig2">2</xref>i-k, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1) and hence tended to let more charge pass compared to wild-type channels (mean charge transfer normalized to conductance at a test potential of − 10 mV: wild-type = 0.09 ± 0.02 C/F, <italic>n</italic> = 8; E1803G = 0.16 ± 0.03 C/F, <italic>n</italic> = 8; <italic>p</italic> = 0.092). The use-dependent inactivation was similar to wild-type (Fig. <xref ref-type="fig" rid="Fig2">2</xref>h, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2). The larger window current may increase neuronal excitability and thereby promote the presence of epileptic seizures in affected patients.</p>
</sec>
<sec id="Sec13">
<title>The BFNIE mutant L1563V exhibits a small depolarizing shift of the inactivation curves</title>
<p id="Par30">Activation, recovery from inactivation, kinetics and use-dependent inactivation did not show relevant differences between L1563V and wild-type channels (Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Table <xref ref-type="table" rid="Tab2">2</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Tables S1–2). However, the inactivation curve was slightly but significantly shifted by about 4 mV in the depolarizing direction (Fig. <xref ref-type="fig" rid="Fig2">2</xref>d, Table <xref ref-type="table" rid="Tab2">2</xref>), which suggests a small gain of channel function.</p>
</sec>
<sec id="Sec14">
<title>Structural modeling of the ID variant R937C predicts a destabilizing effect on the selectivity filter</title>
<p id="Par31">The α-subunits of voltage-gated sodium channels contain four homologous repeats, which contribute to the formation of one central pore region (Fig. <xref ref-type="fig" rid="Fig3">3</xref>a-b). The SCN2A pore region contains the typical DEKA motif, which is formed by four conserved Asp/Glu/Lys/Ala residues (Fig. <xref ref-type="fig" rid="Fig3">3</xref>c). These residues represent the sodium selectivity filter and are therefore crucial for channel function (Shen et al. <xref ref-type="bibr" rid="CR46">2017</xref>). The position of one of these residues (E942) is stabilized by electrostatic interactions with the adjacent R937 (Fig. <xref ref-type="fig" rid="Fig3">3</xref>d). In the R937C variant these interactions cannot be formed by the shorter and uncharged cysteine sidechain resulting in a less defined position of the E942 sidechain. These structural changes offer an explanation for the electrophysiologically observed loss of conductance.<fig id="Fig3"><label>Fig. 3</label><caption><p>Effect of amino acid exchanges on the SCN2A structure. <bold>a</bold> Top view on a model of the SCN2A structure. The four homologous repeats are shown in different colors (blue, cyan, orange, red) and the III-IV domain linker is shown in purple. The site of the pore is marked by a black diamond and the positions of the missense variants investigated in the present study are indicated. The extracellular sequence stretch spanning residues 275–359 has been omitted for clarity. <bold>b</bold> Side-view on the SCN2A structure. Color coding as in (<bold>a</bold>). <bold>c</bold> Model of the SCN2A pore region. The four residues that are critical for Na<sup>+</sup> selectivity are shown in stick presentation. <bold>d</bold> In the wild-type SCN2A (left panel) the sidechain orientation of E942, which is part of the selectivity filter, is stabilized by polar interactions with R937 (see encircled region). These interactions cannot be formed in the R937C variant (right panel) by the shorter and uncharged cysteine sidechain thus impeding fixation of the E942 sidechain (flexibility is indicated by the magenta arrow). <bold>e</bold> E1803 forms interactions with residues Q1510 and P1512 of the III-IV domain linker, which cannot be formed in the (<bold>f</bold>) E1803G variant. The lacking interactions are highlighted by a blue dotted circle. <bold>g</bold> L1342 forms sidechain interactions with W864 of the adjacent repeat. <bold>h</bold> In the L1342P variant, these interactions cannot be formed by the less-extended proline sidechain. <bold>i</bold> L1563 forms hydrophobic interactions within the fourth domain. <bold>k</bold> These interactions are partially lost in the L1563V variant by the shorter valine sidechain (indicated by a blue dotted circle)</p></caption><graphic id="MO3" xlink:href="10020_2019_73_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec15">
<title>Structural modeling of the EE variant E1803G supports altered inactivation properties</title>
<p id="Par32">Residue E1803 is located in the globular C-terminal domain of SCN2A and forms sidechain interactions with two residues of the III-IV domain linker, which cannot be formed in the E1803G variant (Fig. <xref ref-type="fig" rid="Fig3">3</xref>e-f). The III-IV linker plays a key role for fast inactivation of voltage-gated sodium channels (Shen et al. <xref ref-type="bibr" rid="CR46">2017</xref>, Yan et al. <xref ref-type="bibr" rid="CR54">2017</xref>) suggesting that an altered interaction with adjacent domains, as observed for the E1803G variant, might affect inactivation properties.</p>
</sec>
<sec id="Sec16">
<title>The EE variant L1342P is predicted to disturb interactions with the adjacent S4-S5 linker</title>
<p id="Par33">Residue L1342 is located in helix S4 and the effect of a L1342P exchange has been assessed previously based on the isolated helix (Hackenberg et al. <xref ref-type="bibr" rid="CR11">2014</xref>) due to the lack of a homologous 3D-structure at that time. This previous study revealed the lack of a backbone hydrogen bond in the mutant resulting in helix destabilization (Hackenberg et al. <xref ref-type="bibr" rid="CR11">2014</xref>). The availability of homologous structures in 2017 (Yan et al. <xref ref-type="bibr" rid="CR54">2017</xref>, Shen et al. <xref ref-type="bibr" rid="CR46">2017</xref>) allowed the generation of a complete 3D-model for SCN2A and a more comprehensive evaluation of the effects of the L1342P variant. An inspection of the SCN2A model reveals that L1342 forms sidechain interactions with W864, which is located in the S4-S5 linker of the adjacent repeat (Fig. <xref ref-type="fig" rid="Fig3">3</xref>g). These interactions cannot be formed in the L1342P variant because the cyclic proline sidechain cannot adopt an extended conformation required for W864 interaction (Fig. <xref ref-type="fig" rid="Fig3">3</xref>h). Based on this significant structural disturbance and the observation that a number of disease-related variants of Na<sub>v</sub> channels mapped to the interface between S4 and S5 segments in the neighboring repeats (Shen et al. <xref ref-type="bibr" rid="CR46">2017</xref>, Huang et al. <xref ref-type="bibr" rid="CR15">2017</xref>), L1342P is also likely to affect the biophysical properties of SCN2A.</p>
</sec>
<sec id="Sec17">
<title>Hydrophobic interactions within the fourth domain are expected to be diminished in the L1563V BFNIE variant</title>
<p id="Par34">Residue L1563 is located in helix S2 of the fourth voltage-sensing domain and forms hydrophobic sidechain interactions in the core of the domain (Fig. <xref ref-type="fig" rid="Fig3">3</xref>i). In the L1563V variant some of these hydrophobic interactions are lost due to the shorter valine sidechain, but the overall packing of helices S1 and S2 remains unaffected (Fig. <xref ref-type="fig" rid="Fig3">3</xref>k). Thus, this amino acid change is expected to have only a moderate effect on the local structure of the fourth domain.</p>
</sec>
<sec id="Sec18">
<title>Trio WES in the published DEE patient carrying the R102* variant did not reveal a second hit</title>
<p id="Par35">The p.R102* variant is to date the only functionally evaluated protein truncating <italic>SCN2A</italic> variant that leads to an encephalopathic phenotype with seizures (Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>). The reported patch-clamp studies showed a complete loss of channel function for this variant. This patient was reported to exhibit intractable seizures with an onset at age 1y 7m, ASD and severe ID. However, the mother was also reported to have suffered from recurrent febrile seizures until the age of 6y, suggesting the possibility of a second, maternally inherited variant in an epilepsy gene to cause the seizures in the patient and her mother while the de novo truncating <italic>SCN2A</italic> variant could explain the ASD/ID phenotype. This hypothesis is further supported by a recent report of a second patient carrying this variant (Monies et al. <xref ref-type="bibr" rid="CR33">2017</xref>) with a phenotype of severe ID and ASD but no seizures at the age of 6.5 years (personal communication Fowzan S. Alkuraya). To re-evaluate this case, we performed WES in the patient and her parents and filtered for dominant maternally inherited and recessive rare variants in known epilepsy and ID genes, as well as de novo variants. However, we did not detect a likely pathogenic sequence or copy number variant in any known epilepsy gene other than the already known <italic>SCN2A</italic> de novo variant.</p>
</sec>
</sec>
<sec id="Sec19">
<title>Discussion</title>
<p id="Par36">All three variants from patients with ID without seizures studied here showed a complete loss of Na<sub>v</sub>1.2-mediated currents. While the truncating variant L611Vfs*35 is likely to result in nonsense mediated mRNA decay (NMD) in vivo, the stop variant W1716* is located in the last exon and the mRNA should therefore not be subject to NMD (Sanders et al. <xref ref-type="bibr" rid="CR42">2018</xref>), but is expected to direct the synthesis of a C-terminally truncated protein. Thus, the complete loss of function in this mutant must be due to other mechanisms such as protein instability or disturbed transport. In line with this concept, Ben-Shalom et al. (<xref ref-type="bibr" rid="CR1">2017</xref>) showed that in all three investigated truncating <italic>SCN2A</italic> variants no channel could be detected in the membrane of overexpressing HEK293 cells by immunocytochemistry. Of note, multiple variants truncating the protein at later positions (E1777, K1863, I1877) have also been reported to result in complete loss of conductance (Mantegazza et al. <xref ref-type="bibr" rid="CR27">2001</xref>).</p>
<p id="Par37">It was less apparent how the missense variant R937C caused a complete loss of function, as the R937C mutant protein has been previously shown to be correctly located in the cell membrane (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). Its critical location in the pore loop let us speculate that the pore could be completely blocked by the amino acid substitution. Our homology model supports this idea, predicting that R937 stabilizes the glutamate residue which is an essential part of the selectivity filter of Na<sub>v</sub>1.2. The same structural mechanism also applies to the previously described R937H variant causing ASD, which also exhibited no sodium flux (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). Interestingly, two other variants for which no or reduced sodium conductance was reported (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>) are also located in the immediate vicinity of the DEKA selectivity filter (Fig. <xref ref-type="fig" rid="Fig3">3</xref>c). R379H is located near D384 and T1420M near K1422 of the selectivity filter. Thus, it is likely that these variants interfere with sodium permeability by a mechanism similar to that deduced above for the R937C variant.</p>
<p id="Par38">To date, only one other study has functionally evaluated <italic>SCN2A</italic> variants with a non-epileptic phenotype (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S3) (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). In their analysis of variants associated with ASD, all truncating variants and most missense variants were non-conducting, including R937C also investigated in our study. Notably, all non-conducting variants were detected in patients without additional seizures.</p>
<p id="Par39">Both variants causing a phenotype of EE led to profound changes of Na<sub>v</sub>1.2 channel function. While L1342P affected several gating properties, E1803G mainly showed an increased window current caused by a shallower slope of the inactivation curve. So far, 10 <italic>SCN2A</italic> variants detected in EE patients have been studied electrophysiologically (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S3) (Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>, Ogiwara et al. <xref ref-type="bibr" rid="CR34">2009</xref>, Liao, Anttonen, et al. 2010, Lossin et al. <xref ref-type="bibr" rid="CR26">2012</xref>, Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>, Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>, Lauxmann et al. <xref ref-type="bibr" rid="CR22">2018</xref>). Two of them, E1211K and R1312T, exhibited gating changes similar to the ones observed in our mutant L1342P with a negative shift in both activation and inactivation curves and slowed recovery from inactivation (Ogiwara et al. <xref ref-type="bibr" rid="CR34">2009</xref>, Lossin et al. <xref ref-type="bibr" rid="CR26">2012</xref>). Interpretation based on these profoundly altered biophysical properties alone is challenging. However, a computational model of a cortical pyramidal neuron carrying the E1211K variant showed a marked neuronal hyperexcitability with a hyperpolarized spike threshold and an increased spike rate (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S4) (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). We therefore also assume an increase in excitability for neurons carrying the L1342P variant. To date, three other patients carrying the de novo variant L1342P have been reported (Matalon et al. <xref ref-type="bibr" rid="CR28">2014</xref>, Dimassi et al. <xref ref-type="bibr" rid="CR8">2016</xref>, Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>). All four affected patients share a common phenotype with an early seizure onset between age 3 to 6 months, severe ID, muscle tone abnormalities, (progressive) brain atrophy in MRI, and no eye contact (3/4) or cortical visual impairment (1/4). The seizures were intractable in 3/4 patients, and the EEG showed hypsarrhythmia in all three patients where EEG was reported and multifocal epileptic activity in 2/3. Acquired microcephaly and choreiform movements were noted in 2/4 patients.</p>
<p id="Par40">Several missense variants located in the cytoplasmic C-terminal domain (CTD) leading to EE have been reported (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>). Interestingly, the only functionally studied variant, R1882Q, was found to have altered activation and inactivation curves leading to an increased window current, similar to our findings for E1803G. Our structural model predicts that the contacts between the CTD and the inactivation gate are disturbed (Fig. <xref ref-type="fig" rid="Fig3">3</xref>e-f), providing a mechanistic explanation for the altered inactivation properties observed in the E1803G mutant. Interestingly, gating changes leading to a persistent current seem to be a recurrent pathomechanism for <italic>SCN2A</italic> variants detected in EE patients, as this dysfunction has also been described previously as the mechanism of disease for the EE variants A263V (Liao, Anttonen, et al. 2010a) and V423L (Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>). This pathomechanism was also observed in hippocampal pyramidal neurons of a Q54 transgenic mouse model carrying a gain-of-function <italic>Scn2a</italic> variant and showing a progressive epilepsy phenotype (Kearney et al. <xref ref-type="bibr" rid="CR19">2001</xref>). Persistent currents have been found to substantially influence action potential thresholds in axons and are considered to be important for generation of high-frequency action potential bursts in axons and nodes of Ranvier, the main expression sites of Na<sub>v</sub>1.2 (Kole and Stuart <xref ref-type="bibr" rid="CR20">2012</xref>).</p>
<p id="Par41">Most previous electrophysiological studies of BFNIE variants reported a gain-of-function effect, assuming hyperexcitability as the mechanism of disease (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S3) (Scalmani et al. <xref ref-type="bibr" rid="CR44">2006</xref>, Xu et al. <xref ref-type="bibr" rid="CR53">2007</xref>, Misra et al. <xref ref-type="bibr" rid="CR31">2008</xref>, Liao, Deprez, et al. <xref ref-type="bibr" rid="CR25">2010b</xref>, Lauxmann et al. <xref ref-type="bibr" rid="CR21">2013</xref>, Lauxmann et al. <xref ref-type="bibr" rid="CR22">2018</xref>, Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>). Our results for the recurrent BFNIE variant L1563V of a small but significant depolarizing shift of the inactivation curve expected to result in a small gain-of-function are in line with previous studies of this variant (Scalmani et al. <xref ref-type="bibr" rid="CR44">2006</xref>, Xu et al. <xref ref-type="bibr" rid="CR53">2007</xref>, Misra et al. <xref ref-type="bibr" rid="CR31">2008</xref>, Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>). Consistent with the small effect size, molecular modeling (Fig. <xref ref-type="fig" rid="Fig3">3</xref>i-k) showed that the L1563V exchange causes only a small perturbation of the SCN2A structure. In BFNIE, seizures are thought to be self-limited due to the developmental regulation of sodium channels with Na<sub>v</sub>1.2 being partially substituted by Na<sub>v</sub>1.6 (Liao, Deprez, et al. <xref ref-type="bibr" rid="CR25">2010b</xref>, Lauxmann et al. <xref ref-type="bibr" rid="CR21">2013</xref>, Sanders et al. <xref ref-type="bibr" rid="CR42">2018</xref>), while the more pronounced impact of DEE variants on gating properties also observed in this study suggests continued disturbance of neuronal function (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>).</p>
<p id="Par42">Our study of six <italic>SCN2A</italic> variants representing the phenotypic variability known for this gene supports the association of their respective functional impact with the observed patient phenotype. Our data corroborates the assumption that 1) a loss of channel function caused by de novo truncating or missense variants is the underlying mechanism that leads to ID 2) benign epilepsy is due to usually inherited missense variants that lead to a small but relevant gain of channel function and 3) epileptic encephalopathies are the result of profound and lasting gating changes due to de novo missense variants (Ben-Shalom et al. <xref ref-type="bibr" rid="CR1">2017</xref>, Sanders et al. <xref ref-type="bibr" rid="CR42">2018</xref>, Berecki et al. <xref ref-type="bibr" rid="CR2">2018</xref>). Additionally, we suggest that a complete loss of Na<sub>v</sub>1.2 conductance is associated with ID/ASD without seizures, as supported by our own data and the results reported by Ben-Shalom et al. (<xref ref-type="bibr" rid="CR1">2017</xref>), although like in our study long-term follow-up is required since seizures may appear later in childhood. This assumption is in line with data from a heterozygous knock-out mouse model which did not show a seizure phenotype (Planells-Cases et al. <xref ref-type="bibr" rid="CR38">2000</xref>, Middleton et al. <xref ref-type="bibr" rid="CR30">2018</xref>). However, another study on knock-out mouse models despite the absence of behavioral seizures showed very short absence seizures-like patterns in electrocorticography (Ogiwara et al. <xref ref-type="bibr" rid="CR35">2018</xref>), and multiple truncating <italic>SCN2A</italic> variants have been reported in patients with EE that pose exceptions to this proposition (Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>, Carvill et al. <xref ref-type="bibr" rid="CR3">2013</xref>, Horvath et al. <xref ref-type="bibr" rid="CR13">2016</xref>, Moller et al. <xref ref-type="bibr" rid="CR32">2016</xref>, Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>). These truncating variants, though functionally studied in only one case (Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>), are expected to result in a complete loss of function and would therefore well explain the developmental delay and mental impairment but not the development of seizures. A closer look at the respective reports revealed that a patient reported with moderate ID and seizures between the age of 4y 7m and 9y by Wolff et al. (<xref ref-type="bibr" rid="CR52">2017</xref>) and carrying the variant W1716* is the same patient reported in this study, who was suspected but never proven to have seizures of absence type that were later interpreted as rather being mutistic episodes. The patient carrying the de novo variant R102* reported with intractable epilepsy, severe ID and ASD had a mother with recurrent febrile seizures (Kamiya et al. <xref ref-type="bibr" rid="CR16">2004</xref>) suggesting an inherited second hit contributing to the seizure phenotype, albeit not detected by our WES analysis. Accordingly, the same variant in an unrelated patient (Monies et al. <xref ref-type="bibr" rid="CR33">2017</xref>) with follow-up until age 6.5 years did not cause any seizures (personal communication Fowzan S. Alkuraya). The variant R1435* was reported twice as well, once in a patient with ASD, ID and seizures (Trump et al. <xref ref-type="bibr" rid="CR49">2016</xref>) and once in a patient with ID and ASD without seizures at the last follow-up at age 7y 8m (Wolff et al. <xref ref-type="bibr" rid="CR52">2017</xref>), also suggesting a possible second hit or other modifier in the first patient. The assumption of a modifying effect of the genetic background is supported by two studies where different strains of mice carrying the same <italic>Scn2a</italic> variant exhibited differences in seizure severity (Kearney et al. <xref ref-type="bibr" rid="CR19">2001</xref>, Thompson et al. <xref ref-type="bibr" rid="CR48">2017</xref>). In addition, acquired factors such as hypoxia may also impact Na<sub>v</sub>1.2 function (Plant et al. <xref ref-type="bibr" rid="CR39">2016</xref>, Winquist and Cohen <xref ref-type="bibr" rid="CR51">2018</xref>).</p>
<p id="Par43">It has recently been shown that voltage-gated sodium channels assemble and gate as dimers (Clatot et al. <xref ref-type="bibr" rid="CR4">2017</xref>) and that some pathogenic Na<sub>v</sub>1.5 variants exert a dominant-negative effect through impairing trafficking and gating of the wild-type channel (Clatot et al. <xref ref-type="bibr" rid="CR6">2012</xref>, Clatot et al. <xref ref-type="bibr" rid="CR5">2018</xref>). A possible dominant-negative effect was also discussed for pathogenic Na<sub>v</sub>1.2 variants since Kamiya et al. (<xref ref-type="bibr" rid="CR16">2004</xref>) described a reduced whole-cell sodium current when co-expressing the truncating variant R102* together with wild-type. However, this effect disappeared when co-expressing β-subunits. Ben-Shalom et al. (<xref ref-type="bibr" rid="CR1">2017</xref>) did not find a dominant-negative effect either when testing a non-conducting missense variant. Currently it can only be speculated if some of the variants might exert a dominant-negative effect and thereby could explain some outliers of the assumed genotype-phenotype correlation. Hence, this potential pathomechanism should be kept in mind and addressed in future studies using suitable models resembling the heterozygous constellation in the patient.</p>
<p id="Par44">Another point to consider regarding the pathomechanism of <italic>SCN2A</italic> variants is the isoform-dependent effect of Na<sub>v</sub>1.2 variants. Next to the ‘adult’ Na<sub>v</sub>1.2 isoform, which was used by all previous electrophysiological investigations utilizing overexpression of human SCN2A as well as in our study, a ‘neonatal’ isoform exists differing only in a single amino acid at position 209 of the protein (Kasai et al. <xref ref-type="bibr" rid="CR18">2001</xref>, Gazina et al. <xref ref-type="bibr" rid="CR9">2015</xref>). The ‘neonatal’ isoform is expressed at different levels at birth and then decreases until levelling at 10–20% of the ‘adult’ isoform at 20 weeks postnatally in mice (Gazina et al. <xref ref-type="bibr" rid="CR10">2010</xref>). Electrophysiological studies indicate that pathogenic variants can exert different effects in this ‘neonatal’ isoform compared to the predominantly studied ‘adult’ isoform (Xu et al. <xref ref-type="bibr" rid="CR53">2007</xref>, Liao, Deprez, et al. <xref ref-type="bibr" rid="CR25">2010b</xref>).</p>
</sec>
<sec id="Sec20">
<title>Conclusions</title>
<p id="Par45">In conclusion, our work corroborates a strong genotype-phenotype correlation of deleterious <italic>SCN2A</italic> variants and demonstrates that structural modeling can be a useful tool to predict the severity of the variant impact, suggesting its potential as a useful and fast tool to support variant interpretation in diagnostics. We further illustrate the mechanism of how missense variants located in the pore-forming loop can lead to a loss of channel function and how C-terminally located missense variants can exert a severe disturbance on Na<sub>v</sub>1.2 gating properties.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec21">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10020_2019_73_MOESM1_ESM.docx"><label>Additional file 1</label><caption><p>Supplementary Methods. <bold>Table S1.</bold> Activation and inactivation kinetics of Na<sub>v</sub>1.2 wild-type and mutants. <bold>Table S2.</bold> Use-dependent inactivation of Na<sub>v</sub>1.2 wild-type and mutants. <bold>Table S3.</bold> Previous electrophysiological studies of disease causing <italic>SCN2A</italic> variants. <bold>Table S4.</bold> Previous studies using in-silico modeling of neuronal excitability of disease causing <italic>SCN2A</italic> variants. (DOCX 46 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ASD</term>
<def>
<p id="Par5">Autism spectrum disorders</p>
</def>
</def-item>
<def-item>
<term>BFNIE</term>
<def>
<p id="Par6">Benign familial neonatal-infantile epilepsy</p>
</def>
</def-item>
<def-item>
<term>CTD</term>
<def>
<p id="Par7">C-terminal domain</p>
</def>
</def-item>
<def-item>
<term>DEE</term>
<def>
<p id="Par8">Developmental and epileptic encephalopathy</p>
</def>
</def-item>
<def-item>
<term>EE</term>
<def>
<p id="Par9">Epileptic encephalopathy</p>
</def>
</def-item>
<def-item>
<term>EEG</term>
<def>
<p id="Par10">Electroencephalography</p>
</def>
</def-item>
<def-item>
<term>GEFS+</term>
<def>
<p id="Par11">Generalized epilepsy with febrile seizures plus</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p id="Par12">Intellectual disability</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p id="Par13">Magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>Na<sub>v</sub>1.2</term>
<def>
<p id="Par14">Voltage-gated sodium channel type 2</p>
</def>
</def-item>
<def-item>
<term>NMD</term>
<def>
<p id="Par15">Nonsense mediated mRNA decay</p>
</def>
</def-item>
<def-item>
<term>WES</term>
<def>
<p id="Par16">Whole exome sequencing</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<sec id="FPar1">
<title>Funding</title>
<p id="Par46">Supported by radiz—Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases of the University of Zurich to AR, BP and HUZ, by the Swiss National Science Foundation (SNSF) grant 320030_179547 to AR, and by the Forschungskredit UZH and the Josef Huwyler Ruth Bernet-Engeli Stiftung to ABe.</p>
</sec>
<sec id="FPar2" sec-type="data-availability">
<title>Availability of data and materials</title>
<p id="Par47">The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>ABe and MA performed the experiments, analyzed and interpreted data and drafted the manuscript. MZ interpreted the data and revised the manuscript. MV, KS, RBG, AH, LA, BP, JKS, ABa, KY, and YI contributed clinical and/or genetic data. RA contributed to the design of the study. HS performed and analyzed the structural modeling. HUZ and AR designed the study, interpreted the data and wrote the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p>This study was approved by the ethical committee of the Kanton of Zurich (reference StV 11/09) and informed consent was obtained from the patient or their legal guardians.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Consent for publication of molecular and clinical data has been obtained from all reported patients or their legal guardians.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>BP has received travel reimbursement from Nutricia in 2018 and honorarium for a lecture on vitamin B6 dependent seizures by Alexion in 2017 (Bad Nauheim). The remaining authors have no conflicts of interest.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Shalom</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Keeshen</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Berrios</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>An</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Bender</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures</article-title>
<source/>Biol Psychiatry
          <year>2017</year>
<volume>82</volume>
<fpage>224</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.01.009</pub-id>
<pub-id pub-id-type="pmid">28256214</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berecki</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Deerasooriya</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Cilio</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Oliva</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2018</year>
<volume>115</volume>
<fpage>E5516</fpage>
<lpage>E5E25</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1800077115</pub-id>
<pub-id pub-id-type="pmid">29844171</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Heavin</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Yendle</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<fpage>825</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2646</pub-id>
<pub-id pub-id-type="pmid">23708187</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clatot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoshi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shinlapawittayatorn</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voltage-gated sodium channels assemble and gate as dimers</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<fpage>2077</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-02262-0</pub-id>
<pub-id pub-id-type="pmid">29233994</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clatot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Girardeau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Laurita</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Marionneau</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutant voltage-gated Na(+) channels can exert a dominant negative effect through coupled gating</article-title>
<source/>Am J Physiol Heart Circ Physiol
          <year>2018</year>
<volume>315</volume>
<fpage>H1250</fpage>
<lpage>H12H7</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00721.2017</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clatot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ziyadeh-Isleem</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maugenre</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denjoy</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dilanian</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Na(v)1.5 alpha-subunits</article-title>
<source/>Cardiovasc Res
          <year>2012</year>
<volume>96</volume>
<fpage>53</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1093/cvr/cvs211</pub-id>
<pub-id pub-id-type="pmid">22739120</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummins</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sigworth</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Ukomadu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ptacek</surname>
<given-names>LJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis</article-title>
<source/>Neuron
          <year>1993</year>
<volume>10</volume>
<fpage>667</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(93)90168-Q</pub-id>
<pub-id pub-id-type="pmid">8386527</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimassi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Labalme</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Calender</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mignot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boutry-Kryza</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome</article-title>
<source/>Clin Genet
          <year>2016</year>
<volume>89</volume>
<fpage>198</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12636</pub-id>
<pub-id pub-id-type="pmid">26138355</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gazina</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Leaw</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Wimmer</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Aumann</surname>
<given-names>TD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>'Neonatal' Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour</article-title>
<source/>Hum Mol Genet
          <year>2015</year>
<volume>24</volume>
<fpage>1457</fpage>
<lpage>1468</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu562</pub-id>
<pub-id pub-id-type="pmid">25378553</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gazina</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Mokhtar</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Petrou</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Differential expression of exon 5 splice variants of sodium channel alpha subunit mRNAs in the developing mouse brain</article-title>
<source/>Neuroscience
          <year>2010</year>
<volume>166</volume>
<fpage>195</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.12.011</pub-id>
<pub-id pub-id-type="pmid">20006674</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hackenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baumer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sticht</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kroell-Seger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wille</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Infantile epileptic encephalopathy, transient choreoathetotic movements, and hypersomnia due to a De novo missense mutation in the SCN2A gene</article-title>
<source/>Neuropediatrics
          <year>2014</year>
<volume>45</volume>
<fpage>261</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1055/s-0034-1390542</pub-id>
<pub-id pub-id-type="pmid">24710820</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heron</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Crossland</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Andermann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bleasel</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium-channel defects in benign familial neonatal-infantile seizures</article-title>
<source/>Lancet
          <year>2002</year>
<volume>360</volume>
<fpage>851</fpage>
<lpage>852</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(02)09968-3</pub-id>
<pub-id pub-id-type="pmid">12243921</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Demos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shyr</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Race</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: a potential treatment target?</article-title>
<source/>Mol Genet Metab
          <year>2016</year>
<volume>117</volume>
<fpage>42</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2015.11.008</pub-id>
<pub-id pub-id-type="pmid">26647175</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation</article-title>
<source/>Nat Neurosci
          <year>2009</year>
<volume>12</volume>
<fpage>996</fpage>
<lpage>1002</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2359</pub-id>
<pub-id pub-id-type="pmid">19633666</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Structure-based assessment of disease-related mutations in human voltage-gated sodium channels</article-title>
<source/>Protein Cell
          <year>2017</year>
<volume>8</volume>
<fpage>401</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1007/s13238-017-0372-z</pub-id>
<pub-id pub-id-type="pmid">28150151</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamiya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mazaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Okamura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Montal</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline</article-title>
<source/>J Neurosci
          <year>2004</year>
<volume>24</volume>
<fpage>2690</fpage>
<lpage>2698</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3089-03.2004</pub-id>
<pub-id pub-id-type="pmid">15028761</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Ullian</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Isom</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Levinson</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier</article-title>
<source/>Neuron
          <year>2001</year>
<volume>30</volume>
<fpage>105</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(01)00266-5</pub-id>
<pub-id pub-id-type="pmid">11343648</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ueki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nosakowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sugata</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus</article-title>
<source/>Gene
          <year>2001</year>
<volume>264</volume>
<fpage>113</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-1119(00)00594-1</pub-id>
<pub-id pub-id-type="pmid">11245985</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kearney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Plummer</surname>
<given-names>NW</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Kapur</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cummins</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities</article-title>
<source/>Neuroscience
          <year>2001</year>
<volume>102</volume>
<fpage>307</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(00)00479-6</pub-id>
<pub-id pub-id-type="pmid">11166117</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kole</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Signal processing in the axon initial segment</article-title>
<source/>Neuron
          <year>2012</year>
<volume>73</volume>
<fpage>235</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.01.007</pub-id>
<pub-id pub-id-type="pmid">22284179</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauxmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boutry-Kryza</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rivier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hedrich</surname>
<given-names>UB</given-names>
</name>
<name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na(+) current</article-title>
<source/>Epilepsia
          <year>2013</year>
<volume>54</volume>
<fpage>e117</fpage>
<lpage>e121</lpage>
<pub-id pub-id-type="doi">10.1111/epi.12241</pub-id>
<pub-id pub-id-type="pmid">23758435</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauxmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Verbeek</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zaichuk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lemke</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies</article-title>
<source/>Hum Mutat
          <year>2018</year>
<volume>39</volume>
<fpage>1942</fpage>
<lpage>1956</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23619</pub-id>
<pub-id pub-id-type="pmid">30144217</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>290</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.40</pub-id>
<pub-id pub-id-type="pmid">25849321</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Anttonen</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Liukkonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gaily</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain</article-title>
<source/>Neurology
          <year>2010</year>
<volume>75</volume>
<fpage>1454</fpage>
<lpage>1458</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f8812e</pub-id>
<pub-id pub-id-type="pmid">20956790</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Deprez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pitsch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hristova</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy</article-title>
<source/>Brain
          <year>2010</year>
<volume>133</volume>
<fpage>1403</fpage>
<lpage>1414</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awq057</pub-id>
<pub-id pub-id-type="pmid">20371507</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lossin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rogawski</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T</article-title>
<source/>Neurobiol Dis
          <year>2012</year>
<volume>47</volume>
<fpage>378</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2012.05.017</pub-id>
<pub-id pub-id-type="pmid">22677033</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantegazza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Scheuer</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Role of the C-terminal domain in inactivation of brain and cardiac sodium channels</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2001</year>
<volume>98</volume>
<fpage>15348</fpage>
<lpage>15353</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.211563298</pub-id>
<pub-id pub-id-type="pmid">11742069</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matalon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Medne</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>ED</given-names>
</name>
</person-group>
<article-title>Confirming an expanded spectrum of SCN2A mutations: a case series</article-title>
<source/>Epileptic Disord
          <year>2014</year>
<volume>16</volume>
<fpage>13</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">24659627</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Sodium channel mutations in epilepsy and other neurological disorders</article-title>
<source/>J Clin Invest
          <year>2005</year>
<volume>115</volume>
<fpage>2010</fpage>
<lpage>2017</lpage>
<pub-id pub-id-type="doi">10.1172/JCI25466</pub-id>
<pub-id pub-id-type="pmid">16075041</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Middleton</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kneller</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ogiwara</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Montal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamakawa</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered hippocampal replay is associated with memory impairment in mice heterozygous for the Scn2a gene</article-title>
<source/>Nat Neurosci
          <year>2018</year>
<volume>21</volume>
<fpage>996</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-018-0163-8</pub-id>
<pub-id pub-id-type="pmid">29867081</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misra</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Kahlig</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>George</surname>
<given-names>AL</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures</article-title>
<source/>Epilepsia
          <year>2008</year>
<volume>49</volume>
<fpage>1535</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01619.x</pub-id>
<pub-id pub-id-type="pmid">18479388</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moller</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Johannesen</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Talvik</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Talvik</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vaher</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene panel testing in epileptic encephalopathies and familial epilepsies</article-title>
<source/>Mol Syndromol
          <year>2016</year>
<volume>7</volume>
<fpage>210</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.1159/000448369</pub-id>
<pub-id pub-id-type="pmid">27781031</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monies</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Abouelhoda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>AlSayed</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alhassnan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Alotaibi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kayyali</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes</article-title>
<source/>Hum Genet
          <year>2017</year>
<volume>136</volume>
<fpage>921</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-017-1821-8</pub-id>
<pub-id pub-id-type="pmid">28600779</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogiwara</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sawaishi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Osaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mazaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies</article-title>
<source/>Neurology
          <year>2009</year>
<volume>73</volume>
<fpage>1046</fpage>
<lpage>1053</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b9cebc</pub-id>
<pub-id pub-id-type="pmid">19786696</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<mixed-citation publication-type="other">Ogiwara I, Miyamoto H, Tatsukawa T, Yamagata T, Nakayama T, Atapour N, et al. Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. Commun Biol. 2018;1:96. 10.1038/s42003-018-0099-2.</mixed-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Leary</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Brister</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Ciufo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McVeigh</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<fpage>D733</fpage>
<lpage>D745</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv1189</pub-id>
<pub-id pub-id-type="pmid">26553804</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<mixed-citation publication-type="other">Papuc SM, Abela L, Steindl K, Begemann A, Simmons TL, Schmitt B, et al. The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. Eur J Hum Genet. 2018. 10.1038/s41431-018-0299-8.</mixed-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Planells-Cases</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Caprini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rockenstein</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Murre</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice</article-title>
<source/>Biophys J
          <year>2000</year>
<volume>78</volume>
<fpage>2878</fpage>
<lpage>2891</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3495(00)76829-9</pub-id>
<pub-id pub-id-type="pmid">10827969</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<mixed-citation publication-type="other">Plant LD, Marks JD, Goldstein SA. SUMOylation of NaV1.2 channels mediates the early response to acute hypoxia in central neurons. Elife. 2016;5:e20054. 10.7554/eLife.20054.</mixed-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wieczorek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Graf</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wieland</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Endele</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schwarzmayr</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study</article-title>
<source/>Lancet
          <year>2012</year>
<volume>380</volume>
<fpage>1674</fpage>
<lpage>1682</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(12)61480-9</pub-id>
<pub-id pub-id-type="pmid">23020937</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothman</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>NeuroMatic: An integrated open-source software toolkit for acquisition, Analysis and Simulation of Electrophysiological Data</article-title>
<source/>Front Neuroinform
          <year>2018</year>
<volume>12</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.3389/fninf.2018.00014</pub-id>
<pub-id pub-id-type="pmid">29670519</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Cottrell</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Auldridge</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progress in understanding and treating SCN2A-mediated disorders</article-title>
<source/>Trends Neurosci
          <year>2018</year>
<volume>41</volume>
<fpage>442</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2018.03.011</pub-id>
<pub-id pub-id-type="pmid">29691040</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayle</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Milner-White</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>RASMOL: biomolecular graphics for all</article-title>
<source/>Trends Biochem Sci
          <year>1995</year>
<volume>20</volume>
<fpage>374</fpage>
<pub-id pub-id-type="doi">10.1016/S0968-0004(00)89080-5</pub-id>
<pub-id pub-id-type="pmid">7482707</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scalmani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Armatura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zara</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Avanzini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Franceschetti</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing benign familial neonatal-infantile seizures</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<fpage>10100</fpage>
<lpage>10109</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2476-06.2006</pub-id>
<pub-id pub-id-type="pmid">17021166</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bast</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loffler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia</article-title>
<source/>J Neurol
          <year>2016</year>
<volume>263</volume>
<fpage>334</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-015-7984-0</pub-id>
<pub-id pub-id-type="pmid">26645390</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<mixed-citation publication-type="other">Shen H, Zhou Q, Pan X, Li Z, Wu J, Yan N. Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution. Science. 2017;355:eaal4326. 10.1126/science.aal4326.</mixed-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugawara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsurubuchi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Agarwala</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fukuma</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mazaki-Miyazaki</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2001</year>
<volume>98</volume>
<fpage>6384</fpage>
<lpage>6389</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.111065098</pub-id>
<pub-id pub-id-type="pmid">11371648</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>George</surname>
<given-names>AL</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2017</year>
<volume>114</volume>
<fpage>1696</fpage>
<lpage>1701</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1615774114</pub-id>
<pub-id pub-id-type="pmid">28137877</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trump</surname>
<given-names>N</given-names>
</name>
<name>
<surname>McTague</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brittain</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Papandreou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ngoh</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis</article-title>
<source/>J Med Genet
          <year>2016</year>
<volume>53</volume>
<fpage>310</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103263</pub-id>
<pub-id pub-id-type="pmid">26993267</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webb</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sali</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Protein structure modeling with MODELLER</article-title>
<source/>Methods Mol Biol
          <year>2017</year>
<volume>1654</volume>
<fpage>39</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-7231-9_4</pub-id>
<pub-id pub-id-type="pmid">28986782</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winquist</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Integration of biological/pathophysiological contexts to help clarify genotype-phenotype mismatches in monogenetic diseases. Childhood epilepsies associated with SCN2A as a case study</article-title>
<source/>Biochem Pharmacol
          <year>2018</year>
<volume>151</volume>
<fpage>252</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2018.01.003</pub-id>
<pub-id pub-id-type="pmid">29307654</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Johannesen</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Hedrich</surname>
<given-names>UBS</given-names>
</name>
<name>
<surname>Masnada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rubboli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gardella</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders</article-title>
<source/>Brain
          <year>2017</year>
<volume>140</volume>
<fpage>1316</fpage>
<lpage>1336</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awx054</pub-id>
<pub-id pub-id-type="pmid">28379373</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gazina</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A childhood epilepsy mutation reveals a role for developmentally regulated splicing of a sodium channel</article-title>
<source/>Mol Cell Neurosci
          <year>2007</year>
<volume>35</volume>
<fpage>292</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2007.03.003</pub-id>
<pub-id pub-id-type="pmid">17467289</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure of the Nav1.4-beta1 Complex from Electric Eel</article-title>
<source/>Cell
          <year>2017</year>
<volume>170</volume>
<fpage>470</fpage>
<lpage>82.e11</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2017.06.039</pub-id>
<pub-id pub-id-type="pmid">28735751</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Identification of endogenous outward currents in the human embryonic kidney (HEK 293) cell line</article-title>
<source/>J Neurosci Methods
          <year>1998</year>
<volume>81</volume>
<fpage>73</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0270(98)00019-3</pub-id>
<pub-id pub-id-type="pmid">9696312</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>